Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the ...

This new, dead simple prompt technique boosts accuracy on LLMs by up to 76% on non-reasoning tasks

Most modern LLMs are trained as "causal" language models. This means they process text strictly from left to right. When the ...